Skip Navigation

SD Biotechnologies Registers 8 New Raw Materials in ICID

Signifies the enhancement of strategic R&D
Productive research and development continues

News provided by SD Biotechnologies Co., Ltd
July 20, 2018 13:01 KST
  • SNP Red Ginseng Energy Eye Cream with Alpha-Gastrodin included

SEOUL, SOUTH KOREA--(Korea Newswire) July 20, 2018 -- SD Biotechnologies Co., Ltd. (CEO: Park Sul-Woong), well known for its cosmetic brand SNP, announced that 8 raw materials have newly been registered in the International Cosmetic Ingredient Dictionary (ICID).

These new raw materials are developed by the company’s own R&D technologies, and are utilized as a key ingredient of the new product line expansion. For example, Alpha-Gastrodin, the active ingredient of Red Ginseng Energy Eye Cream, is an anti-aging agent newly developed through enzymatic treatment of Gastrodia.

“We are pleased to list the materials developed by our R&D in the International Cosmetic Ingredient Dictionary,” said an official from SD Biotechnologies Co., Ltd., “the company’s endless efforts to be the leader in the competitive cosmetic market will continue. The core material research will continue actively to represent the best products with excellent quality.”

SD Biotechnologies Co., Ltd. presents its own scientific solutions and captivates consumers by superior quality developed by its own R&D center. Over the past years, the R&D center has applied 11 patents and registered 2 patents. Additional 6 patents were registered this year, therefore, 49 patent cases have been filed by SD Biotechnologies Co., Ltd. in total.

Filing of the patents was processed monthly; the company registered a patent of the composition of chlorogenic acid, myrcene, or a mixture of them for improving skin condition and skin exfoliation in January and February. Also a dead skin cell removing patch using the ingredient mentioned above has been registered. From March to May, ‘natural preservative composition containing botanical composition extracts,’ composition of enzyme-treated Artemisia princeps Pamp. Extract for improving skin condition, ‘compositions of myrcene’ for preventing wrinkles, and ‘compositions of chlorogenic acid and rutin compound’ have been registered.

In addition to the patent applications and registrations, SD Biotechnologies Co., Ltd. has been productive on international cosmetic compliance. It is a global health and beauty company increasing international market share by exports to various nations and operating local subsidiaries in China, Vietnam and the US. It achieved 80 cases of CFDA, 36 cases of CPNP, and 49 cases of patent applications and registrations. Also, it has registered 1 utility model and filed 68 design cases.

Contact

SD Biotechnologies Co., Ltd.
Soyeon Kim
82-70-7494-0063
soyeon_kim@sdbiotech.co.kr

This is a news release distributed by Korea Newswire on behalf of this company . Learn more

Share this News Release

Distribute Your News to South Korea

Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
  • 28,000journalists
  • 4,000media outlets
  • 230industry fields
  • 55,000subscribers
Learn more